Details
Stereochemistry | ACHIRAL |
Molecular Formula | C26H28ClNO |
Molecular Weight | 405.96 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CCOC1=CC=C(C=C1)C(=C(\Cl)C2=CC=CC=C2)\C3=CC=CC=C3
InChI
InChIKey=GKIRPKYJQBWNGO-OCEACIFDSA-N
InChI=1S/C26H28ClNO/c1-3-28(4-2)19-20-29-24-17-15-22(16-18-24)25(21-11-7-5-8-12-21)26(27)23-13-9-6-10-14-23/h5-18H,3-4,19-20H2,1-2H3/b26-25+
Molecular Formula | C26H28ClNO |
Molecular Weight | 405.96 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Enclomiphene (Androxal), in development by Repros Therapeutics Inc, is a non-steroidal estrogen receptor antagonist that promotes gonadotropin-dependent testosterone secretion by the testes. Enclomiphene constitutes the trans-stereoisomer of clomiphene citrate, a drug that has been widely prescribed for several decades for the treatment of female ovulatory dysfunction. Because of the antagonistic effects of enclomiphene, the drug has the potential to increase serum testosterone levels in men with secondary hypogonadism by restoring physiological endogenous testosterone secretion while maintaining testicular volume and, potentially, spermatogenesis. In clinical trials conducted to date, enclomiphene demonstrated significant efficacy in the physiological restoration of testosterone levels in males with secondary hypogonadism. The compound also exhibited an unanticipated favorable effect on fasting plasma glucose; this result has been accompanied by rapidly accumulating evidence from other researchers for a bidirectional relationship between low serum testosterone and obesity/metabolic syndrome (syndrome X) in men.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effect of clomiphene citrate treatment on endometrial estrogen and progesterone receptor induction in women. | 1991 Jul |
|
Visual disturbance secondary to clomiphene citrate. | 1995 Apr |
|
Multifactorial activities of nonsteroidal antiestrogens against leukemia. | 2003 |
|
Selective estrogen receptor modulators. | 2003 May |
|
Clomiphene citrate--end of an era? A mini-review. | 2005 Aug |
|
Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 Jun |
|
Complete reversal of adult-onset isolated hypogonadotropic hypogonadism with clomiphene citrate. | 2006 Nov |
|
Use of clomiphene citrate in women. | 2006 Nov |
|
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006 Nov |
|
Oral agents for ovulation induction--clomiphene citrate versus aromatase inhibitors. | 2008 Mar |
|
Enclomiphene, an estrogen receptor antagonist for the treatment of testosterone deficiency in men. | 2009 Feb |
|
Clomiphene and anti-oestrogens for ovulation induction in PCOS. | 2009 Oct 7 |
|
Clomiphene citrate for unexplained subfertility in women. | 2010 Jan 20 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT01534208
Oral, 12.5 mg capsule, taken once daily. Dose may be increased from 12.5 mg to 25 mg if indicated
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2081804
Enclomiphene (10(-5) M) significantly reduced basal and LH-stimulated oestradiol synthesis after 2-4 days of human granulosa cells culture.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:18:19 GMT 2023
by
admin
on
Sat Dec 16 17:18:19 GMT 2023
|
Record UNII |
R6D2UI4FLS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C481
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DB06735
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
15690-57-0
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
1548953
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
CHEMBL954
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
2334
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
C28211
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
100000080225
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
R6D2UI4FLS
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
SUB06521MIG
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
Enclomifene
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | |||
|
m3647
Created by
admin on Sat Dec 16 17:18:19 GMT 2023 , Edited by admin on Sat Dec 16 17:18:19 GMT 2023
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |